Evidence map›Paper›PMID 35404405›Full record

ArticleCancer research2022

Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell Function.

Paramita Chakraborty, Rasesh Y Parikh, Seungho Choi, Danh Tran, Monika Gooz, Zachariah T Hedley, Do-Sung Kim, Dariusz Pytel, Inhong Kang, Satish N Nadig and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Mitochondrial metabolism and cancer therapeutic innovation.Signal transduction and targeted therapy · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 2 countries.

Paramita ChakrabortyDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Rasesh Y ParikhDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-6298-870X
Seungho ChoiDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Danh TranDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Monika GoozDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-6404-5070
Zachariah T HedleyDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Do-Sung KimDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Dariusz PytelDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-3849-7716
Inhong KangDepartment of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina.
Satish N NadigDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Gyda C BeesonDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina.
Lauren BallDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-6780-1679
Meenal MehrotraDepartment of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina.
Hongjun WangDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-7421-1917
Stefano BertoDepartment of Neuroscience, Medical University of South Carolina, Charleston, South Carolina.
Viswanathan PalanisamyDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-5128-2878
Hong LiDepartment of Public Health, Medical University of South Carolina, Charleston, South Carolina.
Shilpak ChatterjeeDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-8428-6434
Paulo C RodriguezDepartment of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0000-0001-7480-6566
Eduardo N MaldonadoDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina.
J Alan DiehlDepartment of Biochemistry, Case Western University, Cleveland, Ohio.
Vamsi K GangarajuDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina.
Shikhar MehrotraDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-5411-9504
Medical University of South Carolina · USCase Western Reserve University · USMoffitt Cancer Center · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI NAKAGAWA, HIROSHI · 2003 to 2023
$31.7M
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20GM103542 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2012 to 2020
$20.2M
UPR, interferon signaling and tumorigenesisP01CA165997 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KOUMENIS, CONSTANTINOS · 2013 to 2023
$10.9M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory ResponseR01CA236379 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MEHROTRA, SHIKHAR · 2020 to 2024
$2.5M
Understanding Metabolic and Epigenetic Cross‐ talk in Potent Anti‐ tumor T cellsR01CA250458 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MEHROTRA, SHIKHAR · 2020 to 2024
$2.3M
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticityR01DE030013 · NIDCR · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI MEHROTRA, SHIKHAR, PALANISAMY, VISWANATHAN · 2020 to 2024
$2.3M
Regulation of piRNA pathway by the Nuclear Pore ComplexR01GM130846 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GANGARAJU, VAMSI · 2019 to 2023
$1.6M
Orbitrap Fusion Lumos ETD Mass SpectrometerS10OD025126 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2018 to 2018
$991k
Confocal/Multiphoton Microscope UpgradeS10OD018113 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LEMASTERS, JOHN J · 2015 to 2015
$570k
High-Content, High-Throughput Multi-Mode Imaging SystemS10OD028663 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GOOZ, MONIKA · 2020 to 2020
$416k
NCI NIH HHS P01 CA098101NCI NIH HHS P01 CA165997NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA236379NCI NIH HHS R01 CA250458NCI NIH HHS R21 CA198646NCI NIH HHS R41 CA239952NIDCR NIH HHS R01 DE030013NIDDK NIH HHS P30 DK123704NIGMS NIH HHS P20 GM103542NIGMS NIH HHS R01 GM130846NIH HHS S10 OD018113NIH HHS S10 OD025126NIH HHS S10 OD028663
6 · The paper itself

Abstract

Mitochondria and endoplasmic reticulum (ER) share structural and functional networks and activate well-orchestrated signaling processes to shape cells' fate and function. While persistent ER stress (ERS) response leads to mitochondrial collapse, moderate ERS promotes mitochondrial function. Strategies to boost antitumor T-cell function by targeting ER-mitochondria cross-talk have not yet been exploited. Here, we used carbon monoxide (CO), a short-lived gaseous molecule, to test whether engaging moderate ERS conditions can improve mitochondrial and antitumor functions in T cells. In melanoma antigen-specific T cells, CO-induced transient activation of ERS sensor protein kinase R-like endoplasmic reticulum kinase (PERK) significantly increased antitumor T-cell function. Furthermore, CO-induced PERK activation temporarily halted protein translation and induced protective autophagy, including mitophagy. The use of LC3-GFP enabled differentiation between the cells that prepare themselves to undergo active autophagy (LC3-GFPpos) and those that fail to enter the process (LC3-GFPneg). LC3-GFPpos T cells showed strong antitumor potential, whereas LC3-GFPneg cells exhibited a T regulatory-like phenotype, harbored dysfunctional mitochondria, and accumulated abnormal metabolite content. These anomalous ratios of metabolites rendered the cells with a hypermethylated state and distinct epigenetic profile, limiting their antitumor activity. Overall, this study shows that ERS-activated autophagy pathways modify the mitochondrial function and epigenetically reprogram T cells toward a superior antitumor phenotype to achieve robust tumor control. SIGNIFICANCE: Transient activation of ER stress with carbon monoxide drives mitochondrial biogenesis and protective autophagy that elicits superior antitumor T-cell function, revealing an approach to improving adoptive cell efficacy therapy.

Indexed as

Carbon MonoxideeIF-2 KinaseApoptosisAutophagyEndoplasmic Reticulum StressHumansT-LymphocytesCarbon MonoxideeIF-2 Kinase

Identifiers

PMID35404405
PMCPMC9117468
OpenAlexW4223510902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.